ישראל - עברית - Ministry of Health

megapharm ltd - borneol; camphene; cineole; menthol; menthone; pinene; pinene - קפסולות - menthol 32 mg; menthone 6 mg; pinene 3.4 mg; borneol 5 mg; camphene 5 mg; cineole 2 mg; pinene 13.6 mg - an adjuvant in the treatment of gall-bladder stones and liver diseases.

ישראל - עברית - Ministry of Health

megapharm ltd - borneol; camphene; cineole; menthol; menthone; pinene; pinene - קפסולות - menthol 32 mg; menthone 6 mg; pinene 3.4 mg; borneol 5 mg; camphene 5 mg; cineole 2 mg; pinene 13.6 mg

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - ceftolozane as sulfate; tazobactam as sodium - אבקה להכנת תמיסה מרוכזת לעירוי - tazobactam as sodium 0.5 g; ceftolozane as sulfate 1 g - ceftolozane and enzyme inhibitor

ישראל - עברית - Ministry of Health

j-c health care ltd - guselkumab - תמיסה להזרקה - guselkumab 100 mg / 1 ml - guselkumab

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as embonate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as embonate 20 mg/vial - pasireotide

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as embonate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as embonate 40 mg/vial - pasireotide

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as embonate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as embonate 60 mg/vial - pasireotide

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 10 mg/vial - pasireotide

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as pamoate - אבקה וממס להכנת תרחיף להזרקה - pasireotide as pamoate 30 mg/vial - pasireotide

ישראל - עברית - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob